drugset / Trial / NCT05659576

Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation

NCT05659576

Phase 2 Active not recruiting 142 enrolled Memorial Sloan Kettering Cancer Center
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to explore options for preventing and reducing symptoms of radiation esophagitis (RE). The researchers will also look what symptoms participants experience, and whether there are differences in weight loss in participants.

Timeline

Start
2022-12-13
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sucralfate Unknown 1 g Oral